GRACE SILVERIO: Open Payments
NPI 1568753416 · HOPEWELL JUNCTION, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 18 payments from 10 companies in 2025. Trend: 2023 $1,395 · 2024 $2,009 · 2025 $700
Food & beverage: $680Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $396 |
| COLOPLAST CORP | 1 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| ABBVIE INC. | 2 | $44 |
| PFIZER INC. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $18 |
Products named: AIRSUPRA, Titan, REXULTI, XIFAXAN, PAXLOVID, BREZTRI, UBRELVY, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
